Phosphorus administration in patients with profound hypophosphatemia

Area of Science:

• Endocrinology
• Nutritional Biochemistry
• Mineral Metabolism

Background:

• Severe hypophosphatemia (≤1.0 mg/dl) impacts vitamin D metabolism.
• Patients often exhibit coexisting liver dysfunction.
• The relationship between phosphate levels and vitamin D activation is not fully understood.

Purpose of the Study:

• To prospectively investigate the influence of severe hypophosphatemia on vitamin D metabolism.
• To determine the effect of phosphorus repletion on vitamin D metabolites.
• To explore the role of serum phosphate in regulating 1,25-dihydroxyvitamin D.

Main Methods:

• Prospective study of 11 patients with severe hypophosphatemia.
• Measurement of plasma 25-hydroxycholecalciferol [25(OH)D] and 1,25-dihydroxycholecalciferol [1,25(OH)2D] before and after intravenous phosphorus.
• Monitoring of serum phosphorus, immunoreactive parathyroid hormone (PTH), and serum calcium.

Main Results:

• Plasma 25(OH)D was significantly lower in hypophosphatemic patients compared to controls.
• Phosphorus administration corrected serum phosphorus but significantly decreased plasma 1,25(OH)2D.
• No significant changes were observed in plasma 25(OH)D, PTH, or serum calcium.
• An inverse correlation between serum phosphorus and plasma 1,25(OH)2D was found (r = -0.62).

Conclusions:

• Serum phosphate plays a crucial role in regulating 1,25-dihydroxyvitamin D levels.
• Hypophosphatemia or phosphorus depletion alters the substrate-product relationship in vitamin D metabolism.
• Phosphorus repletion can lead to a decrease in active vitamin D, independent of PTH or calcium levels.